Article Details

For Risk-Tolerant Investors, Caladrius Biosciences, Inc. (NASDAQ:CLBS) Is Worth A Shot

Retrieved on: 2021-01-28 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

For Risk-Tolerant Investors, Caladrius Biosciences, Inc. (NASDAQ:CLBS) Is Worth A Shot. View article details on hiswai:

Excerpt

In total, 38 institutions holds shares in the company, led by Renaissance Technologies, LLC. As of Sep 29, 2020, the company held over 927.26 ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo